Detalhe da pesquisa
1.
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission.
Blood
; 143(5): 417-421, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37879077
2.
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.
Blood
; 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38551807
3.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34914826
4.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol
; 99(5): 836-843, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38400519
5.
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
J Immunol
; 208(12): 2847-2855, 2022 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35595309
6.
Applying Sydney Triage to Admission Risk Tool (START) to improve patient flow in emergency departments: a multicentre randomised, implementation study.
BMC Emerg Med
; 24(1): 39, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38454324
7.
Cell-Based Therapies for Rotator Cuff Injuries: An Updated Review of the Literature.
Int J Mol Sci
; 25(6)2024 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38542113
8.
Pediatric Age-adjusted Shock Index (SIPA): From Injury to Outcome in Blunt Abdominal Trauma.
J Indian Assoc Pediatr Surg
; 29(1): 33-38, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38405261
9.
Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy-The Surveillance, Epidemiology, and End Results database, 2000-2019.
Cancer
; 129(23): 3805-3814, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37769040
10.
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.
Cancer
; 129(4): 580-589, 2023 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36448227
11.
Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity.
Cancer
; 129(14): 2192-2200, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37016930
12.
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.
Cancer
; 129(7): 1017-1029, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36715486
13.
Acalabrutinib in treatment-naive chronic lymphocytic leukemia.
Blood
; 137(24): 3327-3338, 2021 06 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33786588
14.
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.
Haematologica
; 108(10): 2626-2638, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37078252
15.
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors.
Am J Hematol
; 98(4): 658-665, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36683287
16.
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results.
Am J Hematol
; 98(3): 493-501, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36600670
17.
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1.
Am J Hematol
; 98(8): 1196-1203, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37183966
18.
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.
Am J Hematol
; 98(10): 1619-1626, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37485584
19.
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
Am J Hematol
; 98(11): 1711-1720, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37635400
20.
AtTLP2, a Tubby-like protein, plays intricate roles in abiotic stress signalling.
Plant Cell Rep
; 42(2): 235-252, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36437308